DIRECTORY
BIOTECH
Pharmaclient

   

Quick Click ! Monthly news Home-Site Contactexpress Faqs Legends Search Companies Events Environment Memories Home-Biotech

Abcys | AB Science | Adocia | Advicenne Pharma | Affichem | Agate Bioservices | Aisa Therapeutics | Alfact Innovation | AliX | Alizé Pharma | Alphelys | Ambiotis | Anaconda Pharma | Aptys Pharmaceuticals | Ariana Pharmaceuticals | Atlantic Bone Screen | Aureus Pharma | B Cell Design | BioAlliance Pharma | Biocortech | BioCydex | BioMedical Diagnostics | Biométhodes | Biom'up | BioProtein Technologies | BioQuanta | BioSystems International | BMSystems (Bio-modeling) | BT Pharma | Carmat | Cellectis | Cellial Technologies | CellVax | CellVir | Cerenis Therapeutics | Cezanne | CliniGenetics | Covalab | Cytheris | Cytomics | Cytoo | DBV Technologies | DNA Therapeutics | Domain Therapeutics | Dynabio | EchoSens | Edelris | Endotis Pharma | Epixis | ERYtech Pharma | Exonhit | Eye Tech Care | Flamel Technologies | Fluofarma | GemacBio | Genepep | Genewave | Genfit | GenOdyssee | Genomic Vision | GenoSafe | GenoScience Pharma | Genoscreen | GenOway | GTP Technology | Helios Biosciences | Hybrigenics | Hyphen BioMed | Imagene | ImmunId | Immutep | Imstar | In-Cell-Art | Indicia Biotechnology | InGen Biosciences (AbAg) | Innate Pharma | InnaVirVax | Innovative Health Diagnostics | IntegraGen | Ipsogen | I-Stem | Karcinolys | Keosys | LibraGen | Magnisense | Mapreg | MAT Biopharma | Mauna Kea Technologies | Medesis Pharma | Mellitech | Metabolys | MicroBioChips | MilleGen | MitoProd | Murigenetics | Mutabilis | Myosix | NanoBiotix | Neorphys | Neovacs | Netris-Pharma | Neuronax | NicOx | Nokad | Nosopharm | Nova Decision | Novagali | NovoCIB | Novotec | Obe Therapy | Oligovax | Oncodesign | Oroxcell | Oxincell | Palumed | PharmaLeads | Pharmaxon | Pharnext | PhenoPro | Pherecydes Pharma | PolyIntell | PraXcell | Proteogenix | Protéus | Protexel | PX’Therapeutics | Quantum Genomics | Rhenovia Pharma | ScarCell Therapeutics | Sepal Pharma | Serial Genetics | Sisène Biotechnologies | Skuld-Tech | Synapcell | Synprosis | Tc Land Expression | Theraclion | TheraVectys | Transgene | Trophos | TxCell | UroGene | UROsphere | Urrma | Vaxon Biotech | Vectalys | VigiCell | Vivalis | XenTech | Zeta Biotech |

* LIBRAGEN *


2001 - Midi-Pyrénées
Toulouse
www.libragen.com

Design, Manufacturing
(also, Contract, Research)
Key words: Bioprocesses, Enzymes, Bio-catalysis, Meta-Dna libraries, Small molecules identification, Micro-organisms, Auriose
Mission: to discover, develop and improve innovative bioprocesses for the industrial production of healthcare molecules, by building on bacterial diversity, based on cooperation with 4 Public research units (Inra, Insa, Lyon CNRS, Orsay CNRS)
Clients: Pharmaceutical industry, Chemical industry, Cosmetics industry, Food industry
contact@libragen.com

Age: 9 year(s)

Identity
TYPE/MANAGEMENT/INVESTORSFINANCES/STATUS

Personal venture |
Managing Dir.-CEO: Nalin (Renaud) [born 1967, Ph.D., ex-CRO]
Sc.Dir.-CSO: Lefèvre (Fabrice) [Ph.D., Insa, ex-Protéus]
Fin.Dir.-CFO:
BusDev:
Financers (Hist.): Bioam, Galia Gestion

Turnover (M€) : 0.18 (2007)
Total funding (M€) : 3.0
Last funding (M€) : 2.2
Focus : Studies
Position : Proof-of-Concept
Company confirm : 16-Jun-2008

History
DATEMILESTONETYPETIME
2010 .01 Sustainable process intensification in the manufacturing of its cosmetic actives, Inoveol MKTG [8 years]
2008 .12 Launch of Inoveol (www.inoveol.com) actives (stable polyphenol cosmetic compounds) on the US market MKTG [7 years]
2008 .09 Partnering research agreement with DSM, to co-develop transaminases for production of chiral amines R&D [7 years]
2006 .01 Partnering research agreement with Pierre Fabre, enzymatic synthesis R&D [4 years]
2005 .11 Partnering research agreement with Minakem on biocatalysis and organic synthesis (green chemistry, fine chemicals) R&D [4 years]
2005 .06 Nomination : Fabrice Lefèvre, as CSO ORGN [4 years]
2004 .09 Company move from Lyon to Toulouse ORGL [3 years]
2004 .05 1st round-financing : 2.2 M€, by BIOAM, Galia Gestion, and IRDI (Midi Pyrénées V.C.) RFINA [3 years]
2001 .03 Seed financing : 0.75 M€, by Bioam SFIN [0 year]
2001 .02 Company founded by Renaud Nalin and Pascal Simonet [CNRS] in Lyon ORGF [0 year]

Actualisation / Updating: 05-Feb-2010


Pharmaclient est le site-conseil de la Valorisation Client en Pharma...
Pour toute Mission, Inscription à la Pharmagalerie, Insertion dans la base Biotech, ou Question: CONTACT
Pour retourner à la page d'accueil Biotech: BIENVENUE !

Haut de page :

Copyright J.H. Huber, Pharmaclient 2001-2010.

Pharmaclient, le site de la valorisation client en Pharma, est la vitrine des activités de conseil de Jean Huber: Stratégie, Communication, Relation Client en Pharma.